Medicare/CMSTraditional Medicare · Administrative · General · Ophthalmology, NephrologyMedium impact
2026-04-02 - HHS & CMS Announce Healthcare Advisory Committee Members to Improve Patient Care and Modernize the U.S. Healthcare System
Act
by Apr 7, 2026
Effective date
Apr 7, 2026
Identified
Apr 3, 2026
Summary
This MLN Connects newsletter contains multiple updates including OPPS Drug Acquisition Cost Survey deadline extension to April 7, 2026, XPHOZAN drug inclusion in ESRD bundled payment, and billing guidance for E&M services with intravitreal injections. Key billing code changes include status indicator updates and coverage determinations.
Get alerts when payers change rules like this one
We check Medicare/CMS and other payers every day and email you when a change matches your specialty and state.
01OPPS hospitals listed in the provider table must submit drug acquisition cost data using the online system and complete attestation forms.
02Immediately: Update billing systems to reflect HCPCS code Q0599 status indicator change from E1 to K.
03Review E&M billing with intravitreal injections to ensure modifier 25 is only used for significant, separately identifiable services unrelated to the injection procedure.
Codes mentioned
Q0599C1735C1736
Original notice
2026-04-02 - HHS & CMS Announce Healthcare Advisory Committee Members to Improve Patient Care and Modernize the U.S. Healthcare System
cms.gov · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.